Related Experiment Videos
[Pneumonia: what's new?]
1Institut für Medizinische Mikrobiologie, Universität Bern. taeuber@imm.unibe.ch
Abstract:
Pneumonia continues to be one of the most important infectious diseases which often leads to hospital admissions and is occasionally fatal. The spectrum of causative organisms, their sensitivity pattern to antibiotics, diagnostic tools, and available antibiotics are continually changing. Currently, the most disquieting trend is the increasing development of resistance to commonly used antibiotics by the pneumococcus. Although this trend has thus far been observed primarily in other countries, it will most likely not spare Switzerland. Rational empiric therapy must include careful clinical assessment of the patient, knowledge of the spectrum of organisms locally causing pneumonias, including their resistance patterns, as well as a prognostic assessment of the patient. Using these factors, possible antibiotic schemes for empiric therapy of community-acquired pneumonia are reviewed.
Insights
Pneumonia remains a significant infectious disease. Rising antibiotic resistance in pneumococcus necessitates informed empiric therapy for community-acquired pneumonia.
Area of Science:
- Infectious Diseases
- Microbiology
- Pharmacology
Context:
- Pneumonia is a leading cause of hospitalization and mortality.
- Evolving spectrum of causative pathogens and antibiotic resistance patterns.
- Increasing global concern over antimicrobial resistance in Streptococcus pneumoniae.
Purpose:
- To review current trends in pneumonia etiology and antibiotic resistance.
- To outline rational empiric antibiotic therapy for community-acquired pneumonia.
- To inform clinical decision-making in the face of changing resistance patterns.
Summary:
- Pneumonia's causative agents and their antibiotic sensitivities are dynamic.
- Increasing antibiotic resistance, particularly in pneumococcus, is a major challenge.
- Rational empiric therapy requires clinical assessment, local resistance data, and prognostic evaluation.
Impact:
- Guides appropriate antibiotic selection for community-acquired pneumonia.
- Highlights the critical need for monitoring local resistance trends.
- Aims to optimize treatment outcomes and combat antimicrobial resistance.